Abstract
Multicenter, Real-World Study in Patients with R/R Large B-Cell Lymphoma (LBCL) Who Received Lisocabtagene Maraleucel (liso-cel) in the United States (US)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have